{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:30:27Z","timestamp":1769603427141,"version":"3.49.0"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.2169\/internalmedicine.1457-18","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T22:30:26Z","timestamp":1539729026000},"page":"713-718","source":"Crossref","is-referenced-by-count":2,"title":["Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan"],"prefix":"10.2169","volume":"58","author":[{"given":"Zenshi","family":"Miyake","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Tsukuba Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Nakamagoe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Ezawa","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneaki","family":"Yoshinaga","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Tsukuba Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tamaoka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Ando Y. Amyloidosis and neurological disorders: treatable amyloidosis. Rinsho Shinkeigaku 55: 797-803, 2015 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.cn-000775"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Westermark P, Benson MD, Buxbaum JN, et al. A primer of amyloid nomenclature. Amyloid 14: 179-183, 2007.","DOI":"10.1080\/13506120701460923"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ando Y, Coelho T, Berk JL, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis 8: 31-48, 2013.","DOI":"10.1186\/1750-1172-8-31"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Koike H, Sobue G. Late-onset familial amyloid polyneuropathy in Japan. Amyloid 19: 55-57, 2012.","DOI":"10.3109\/13506129.2012.674580"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Koike H, Nakamura T, Hashizume A, et al. Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy. J Neurol 264: 2293-2302, 2017.","DOI":"10.1007\/s00415-017-8629-2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sato C, Takaya T, Mori S, et al. An isolated case of late-onset amyloidogenic transthyretin type familial amyloid polyneuropathy associated with a mutant transthyretin substituting methionine for valine at position 30 showing latent progressive cardiac involvement confirmed by serial annual electrocardiograms. Intern Med 56: 163-168, 2017.","DOI":"10.2169\/internalmedicine.56.7562"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Koike H, Sobue G. Clinicopathological features of familial amyloid polyneuropathy. Rinsho Shinkeigaku 51: 1134-1137, 2011.","DOI":"10.5692\/clinicalneurol.51.1134"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Koike H, Hashimoto R, Tomita M, et al. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Amyloid 18: 53-62, 2011.","DOI":"10.3109\/13506129.2011.565524"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kawaji T, Ando Y, Ando E, et al. Transthyretin-related vitreous amyloidosis in different endemic areas. Amyloid 17: 105-108, 2010.","DOI":"10.3109\/13506129.2010.527068"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Tojo K, Tsuchiya-Suzuki A, Sekijima Y, et al. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy. Amyloid 17: 32-35, 2010.","DOI":"10.3109\/13506121003619369"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Koike H, Tanaka F, Hashimoto R, et al. Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. J Neurol Neurosurg Psychiatry 83: 152-158, 2012.","DOI":"10.1136\/jnnp-2011-301299"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mankad AK, Shah KB. Transthyretin cardiac amyloidosis. Curr Cardiol Rep 19: 97-107, 2017.","DOI":"10.1007\/s11886-017-0911-5"},{"key":"13","unstructured":"13. Sekijima Y. New treatment for familial amyloid polyneuropathy. Shinshu Igaku Zasshi 62: 185-187, 2014 (in Japanese, Abstract in English)."},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Sekijima Y, Tojo K, Morita H, et al. Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis. Amyloid 22: 79-83, 2015.","DOI":"10.3109\/13506129.2014.997872"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Coelho T, Maia LF, Martins da Silva A, et al. Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology 79: 785-792, 2012.","DOI":"10.1212\/WNL.0b013e3182661eb1"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/5\/58_1457-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T05:37:54Z","timestamp":1551505074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/5\/58_1457-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1457-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,1]]}}}